Heart and Lung Transplants from HCV-Infected Donors to Uninfected Recipients.
Ann E WoolleySteve K SinghHilary J GoldbergHari R MallidiMichael M GivertzMandeep R MehraAntonio CoppolinoAmanda E KusztosMegan E JohnsonKaiwen ChenEsther A HaddadJohn FanikosDavid P HarringtonPhillip C CampLindsey R Badennull nullPublished in: The New England journal of medicine (2019)
In patients without HCV infection who received a heart or lung transplant from donors with hepatitis C viremia, treatment with an antiviral regimen for 4 weeks, initiated within a few hours after transplantation, prevented the establishment of HCV infection. (Funded by the Mendez National Institute of Transplantation Foundation and others; DONATE HCV ClinicalTrials.gov number, NCT03086044.).